Human Health Holdings Management

Management Kriterienprüfungen 2/4

Human Health Holdings' CEO ist Kin Ping Chan , ernannt in Jun 2015, hat eine Amtszeit von 9.08 Jahren. Die jährliche Gesamtvergütung beträgt HK$4.90M , bestehend aus 49.4% Gehalt und 50.6% Boni, einschließlich Aktien und Optionen des Unternehmens. besitzt direkt 1.8% der Aktien des Unternehmens, im Wert von HK$6.99M . Die durchschnittliche Betriebszugehörigkeit des Managementteams und des Verwaltungsrats beträgt 9 Jahre bzw. 9.1 Jahre.

Wichtige Informationen

Kin Ping Chan

Geschäftsführender

HK$4.9m

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	49.4%
Amtszeit als Geschäftsführer	9.3yrs
Eigentum des Geschäftsführers	1.8%
Durchschnittliche Amtszeit des Managements	9.2yrs
Durchschnittliche Amtszeit der Vorstandsmitglieder	9.3yrs

Jüngste Management Updates

Recent updates

Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Sep 13

Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Jan 23

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

Mar 21

Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Nov 26

Analyse der Geschäftsführervergütung

Wie hat sich die Vergütung von Kin Ping Chan im Vergleich zu den Einnahmen von Human Health Holdings verändert?
Datum	Gesamtvergütung	Gehalt	Unternehmensgewinne
Jun 30 2024	n/a	n/a	HK$24m
Mar 31 2024	n/a	n/a	-HK$22m
Dec 31 2023	n/a	n/a	-HK$67m
Sep 30 2023	n/a	n/a	HK$57m
Jun 30 2023	HK$5m	HK$2m	HK$181m
Mar 31 2023	n/a	n/a	HK$367m
Dec 31 2022	n/a	n/a	HK$553m
Sep 30 2022	n/a	n/a	HK$464m
Jun 30 2022	HK$3m	HK$2m	HK$375m
Mar 31 2022	n/a	n/a	HK$297m
Dec 31 2021	n/a	n/a	HK$218m
Sep 30 2021	n/a	n/a	HK$181m
Jun 30 2021	HK$2m	HK$2m	HK$144m
Mar 31 2021	n/a	n/a	HK$59m
Dec 31 2020	n/a	n/a	-HK$27m
Sep 30 2020	n/a	n/a	-HK$33m
Jun 30 2020	HK$2m	HK$2m	-HK$40m
Mar 31 2020	n/a	n/a	-HK$11m
Dec 31 2019	n/a	n/a	HK$19m
Sep 30 2019	n/a	n/a	HK$23m
Jun 30 2019	HK$2m	HK$2m	HK$27m
Mar 31 2019	n/a	n/a	HK$26m
Dec 31 2018	n/a	n/a	HK$25m
Sep 30 2018	n/a	n/a	HK$24m
Jun 30 2018	HK$2m	HK$2m	HK$24m

Vergütung im Vergleich zum Markt: Kin PingDie Gesamtvergütung ($USD627.42K) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt Hong Kong ($USD231.79K).

Entschädigung vs. Einkommen: Kin PingDie Bezüge der Mitarbeiter sind um mehr als 20 % gestiegen, während die Unternehmensgewinne im vergangenen Jahr um mehr als 20 % gesunken sind.

Geschäftsführer

Kin Ping Chan (60 yo)

9.3yrs

Amtszeit

HK$4,902,000

Vergütung

Mr. Kin Ping Chan, BBS, J.P, serves as the Chairman of the Board at Human Health Holdings Limited and has been its Chief Executive Officer and Executive Director since June 9, 2015. Mr. Chan is a Co-Owner...

Führungsteam

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Kin Ping Chan	Chairman of the Board & CEO	9.3yrs	HK$4.90m	1.8% HK$ 5.5m
Chun Pong Poon	COO & Executive Director	11yrs	HK$4.88m	0.13% HK$ 388.8k
Lai Sheung Pang	Chief Medical Officer & Executive Director	no data	HK$4.90m	keine Daten
Siu Keung Seto	Co-Head of Dental Unit	9.2yrs	keine Daten	keine Daten
Wai Man Lau	Co-Head of Dental Unit	9.2yrs	keine Daten	keine Daten
Ching Yan Man	Company Secretary	7.3yrs	keine Daten	keine Daten

9.2yrs

Durchschnittliche Betriebszugehörigkeit

57.5yo

Durchschnittliches Alter

Erfahrenes Management: Das Managementteam von 1419 ist erfahren und erfahren (durchschnittliche Amtszeit: 8.8 Jahre).

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Kin Ping Chan	Chairman of the Board & CEO	9.3yrs	HK$4.90m	1.8% HK$ 5.5m
Chun Pong Poon	COO & Executive Director	9.3yrs	HK$4.88m	0.13% HK$ 388.8k
Lai Sheung Pang	Chief Medical Officer & Executive Director	9.3yrs	HK$4.90m	keine Daten
Yue Kwong Chan	Independent Non-Executive Director	8.7yrs	HK$180.00k	keine Daten
Sun Wing Lui	Independent Non-Executive Director	8.7yrs	HK$180.00k	keine Daten
Kar Tim Sin	Independent Non-Executive Director	8.7yrs	HK$180.00k	keine Daten
Kin Hung Kwong	Member of Doctor Advisory Board	15.1yrs	keine Daten	keine Daten
Huen Lee	Member of Doctor Advisory Board	11.9yrs	keine Daten	keine Daten

9.3yrs

Durchschnittliche Betriebszugehörigkeit

58.5yo

Durchschnittliches Alter

Erfahrener Vorstand: 1419Die Vorstandsmitglieder gelten als erfahren (8.9 Jahre durchschnittliche Amtszeit).

Human Health Holdings Management

Management Kriterienprüfungen 2/4

Wichtige Informationen

Jüngste Management Updates

Human Health Holdings Limited Announces Board and Committee Changes

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2024

Human Health Holdings Limited, Annual General Meeting, Dec 07, 2023

Less than half of directors are independent

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2022

Less than half of directors are independent

Recent updates

Human Health Holdings Limited Announces Board and Committee Changes

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2024

Market Participants Recognise Human Health Holdings Limited's (HKG:1419) Revenues

Human Health Holdings Limited to Report Q4, 2024 Results on Sep 25, 2024

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2024

First half 2024 earnings released: EPS: HK$0.053 (vs HK$0.71 in 1H 2023)

Human Health Holdings Limited to Report First Half, 2024 Results on Feb 27, 2024

Human Health Holdings Limited's (HKG:1419) Share Price Is Matching Sentiment Around Its Earnings

Investor sentiment improves as stock rises 16%

Investor sentiment deteriorates as stock falls 16%

Upcoming dividend of HK$0.16 per share at 12% yield

Human Health Holdings Limited, Annual General Meeting, Dec 07, 2023

New minor risk - Profit margin trend

Human Health Holdings Limited Proposes Final Dividend for the Year Ended June 30, 2023, Payable on 29 December 2023

Human Health Holdings Limited to Report Fiscal Year 2023 Results on Sep 26, 2023

First half 2023 earnings released: EPS: HK$0.71 (vs HK$0.24 in 1H 2022)

First half 2023 earnings released: EPS: HK$0.71 (vs HK$0.24 in 1H 2022)

Human Health Holdings Limited to Report First Half, 2023 Results on Feb 24, 2023

Investor sentiment improved over the past week

Upcoming dividend of HK$0.30 per share

Less than half of directors are independent

Full year 2022 earnings released: EPS: HK$0.99 (vs HK$0.38 in FY 2021)

Full year 2022 earnings released: EPS: HK$0.99 (vs HK$0.38 in FY 2021)

Human Health Holdings Limited, Annual General Meeting, Dec 02, 2022

Investor sentiment improved over the past week

Human Health Holdings Limited to Report Fiscal Year 2022 Results on Sep 29, 2022

Human Health Holdings Limited Provides Earnings Guidance for the Year Ended 30 June 2022

Less than half of directors are independent

Investor sentiment improved over the past week

Human Health Holdings (HKG:1419) Seems To Use Debt Quite Sensibly

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Human Health Holdings Limited to Report First Half, 2022 Results on Feb 25, 2022

Human Health Holdings Limited Provides Unaudited Financial Guidance for the Six Months Ended December 31, 2021

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Upcoming dividend of HK$0.12 per share

Shareholders May Be More Conservative With Human Health Holdings Limited's (HKG:1419) CEO Compensation For Now

Full year 2021 earnings released: EPS HK$0.38 (vs HK$0.11 loss in FY 2020)

Full year 2021 earnings released: EPS HK$0.38 (vs HK$0.11 loss in FY 2020)

Is Human Health Holdings (HKG:1419) Using Too Much Debt?

First half 2021 earnings released: EPS HK$0.045 (vs HK$0.008 in 1H 2020)

Estimating The Fair Value Of Human Health Holdings Limited (HKG:1419)

Human Health Holdings Limited to Report First Half, 2021 Results on Feb 24, 2021

New 90-day high: HK$0.68

Is Human Health Holdings (HKG:1419) Weighed On By Its Debt Load?

New 90-day low: HK$0.55

New 90-day low: HK$0.58

New 90-day low: HK$0.60

Human Health Holdings Limited Resolves Not to Declare Any Final Dividend for Financial Year 2020

Full year earnings released - HK$0.11 loss per share

Analyse der Geschäftsführervergütung

Geschäftsführer

Amtszeit

Vergütung

Führungsteam

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter

Vorstandsmitglieder

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter